Skip to content

Mirion

US · MIR #2362 by market cap Listed 1970
16.07 -1.11 -6.46%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

✦ Quant Ownership Signal how this is computed

Distributing
  • The number of reporting institutions increased by 3 in the most recent period (2026/Q3).
  • Total institutional ownership fell 0.8 percentage points.

Ownership vs. money flow

Aligned

Institutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Institutional ownership

Held by institutions
111.95% -0.81pp
Institutions
432 +3
As of
2026/Q3 vs. prior period

Holder types

Mutual Fund86.67%
Hedge Fund14.77%
Sovereign Wealth Fund4.30%
Public Company3.71%
Individual/Insider3.60%
Government Pension Fund1.24%
Private Company0.58%
Insurance Company0.43%
Family Office/Trust0.16%

Top holders as of 2026-09-30

BlackRock 16.03% · 38.44M sh
Vanguard Portfolio Management, LLC 7.48% · 17.93M sh
T. Rowe Price Group, Inc. 6.14% · 14.71M sh
Vanguard Capital Management, LLC 4.42% · 10.59M sh
Kuwait Investment Authority 4.24% · 10.17M sh
State Street Global Advisors 4.13% · 9.89M sh
Alyeska Investment Group, L.P. 3.98% · 9.53M sh
Omega Advisors, Inc. 3.50% · 8.38M sh
Goldman Sachs Asset Management, L.P. 3.13% · 7.50M sh
FMR 3.01% · 7.32M sh
Geode Capital Management, LLC 2.54% · 6.09M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 21 buys · 29 sells

NameRoleStake
Lawrence Kingsley Independent Director 1.49%
Thomas Logan Founder, Medical Group President, CEO & Chairman 1.47%
Brian Schopfer CFO & Medical Group President 0.38%
Loic Eloy Group President of Nuclear & Safety Technologies 0.04%
Emmanuelle Lee Executive VP, Chief Legal Officer, Chief Compliance Officer & Secretary 0.03%
Steven Etzel Independent Director 0.03%
Jody Markopoulos Independent Director 0.03%
John Kuo Independent Director 0.03%
Kenneth Bockhorst Lead Independent Director 0.03%
Robert Cascella Independent Director 0.02%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-09-29 Lawrence Kingsley Independent Director Other Acquisition +1,333 $14.34
2026-09-29 Jody Markopoulos Independent Director Other Acquisition +1,333 $14.34
2026-09-01 Brian Schopfer CFO & Medical Group President Open Market Acquisition +20,000 $15.60
2026-06-29 Lawrence Kingsley Independent Director Other Acquisition +1,095 $17.46
2026-05-12 Robert Cascella Independent Director Other Acquisition +7,383 --
2026-05-12 John Kuo Independent Director Other Acquisition +7,383 --
2026-05-12 Lawrence Kingsley Independent Director Other Acquisition +7,383 --
2026-05-12 Steven Etzel Independent Director Other Acquisition +7,383 --
2026-05-12 Jody Markopoulos Independent Director Other Acquisition +7,383 --
2026-05-12 Sheila Rege Independent Director Other Acquisition +7,383 --
2026-05-12 Kenneth Bockhorst Lead Independent Director Other Acquisition +7,383 --
2026-05-06 Christopher Moore Chief Accounting Officer Open Market Disposition -8,400 $19.64
2026-05-05 Thomas Logan Founder, Medical Group President, CEO & Chairman Other Disposition -311,851 --
2026-03-31 Emmanuelle Lee Executive VP, Chief Legal Officer, Chief Compliance Officer & Secretary Sale to Issuer -4,680 $18.59
2026-03-31 Thomas Logan Founder, Medical Group President, CEO & Chairman Sale to Issuer -22,614 $18.59
2026-03-31 Brian Schopfer CFO & Medical Group President Sale to Issuer -7,377 $18.59
2026-03-31 Alison Ulrich Chief Human Resources Officer Sale to Issuer -2,053 $18.59
2026-03-31 Christopher Moore Chief Accounting Officer Sale to Issuer -1,903 $18.59
2026-03-30 Lawrence Kingsley Independent Director Other Acquisition +1,104 $17.32
2026-03-01 Thomas Logan Founder, Medical Group President, CEO & Chairman Sale to Issuer -147,834 $21.61

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Mirion discussion 0 comments

Add a comment